200,000+ products from a single source!
sales@angenechem.com
CAS No: 13636-18-5 Catalog No: AG0011T3 MDL No:
Title | Journal |
---|---|
Real-time 2D separation by LC × differential ion mobility hyphenated to mass spectrometry. | Analytical and bioanalytical chemistry 20120301 |
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
Fendiline-evoked [Ca2+]i rises and non-Ca2+-triggered cell death in human oral cancer cells. | Human & experimental toxicology 20090101 |
Interaction of antagonists with calmodulin: insights from molecular dynamics simulations. | Journal of medicinal chemistry 20080612 |
[Role of apoptosis in the kidney after reperfusion]. | Orvosi hetilap 20080217 |
2'-hydroxy-fendiline analogues as potent relaxers of isolated arteries. | European journal of pharmacology 20070430 |
Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
Quantitative structure-pharmacokinetic relationships for drug clearance by using statistical learning methods. | Journal of molecular graphics & modelling 20060301 |
Spectrofluorimetric determination of fendiline in tablets. | Die Pharmazie 20051001 |
3-Chloro,4-methoxyfendiline is a potent GABA(B) receptor potentiator in rat neocortical slices. | European journal of pharmacology 20050110 |
Calcium sensing receptors as integrators of multiple metabolic signals. | Cell calcium 20040301 |
Calcimimetic and calcilytic drugs: just for parathyroid cells? | Cell calcium 20040301 |
Arylalkylamines are a novel class of positive allosteric modulators at GABA(B) receptors in rat neocortex. | European journal of pharmacology 20020906 |
The anti-anginal drug fendiline elevates cytosolic Ca(2+) in rabbit corneal epithelial cells. | Life sciences 20020719 |
Fendiline mobilizes intracellular Ca2+ in Chang liver cells. | Clinical and experimental pharmacology & physiology 20010901 |
Fendiline, an anti-anginal drug, increases intracellular Ca2+ in PC3 human prostate cancer cells. | Cancer chemotherapy and pharmacology 20010701 |
Effects of the antianginal drug fendiline on Ca2+ movement in hepatoma cells. | Human & experimental toxicology 20010701 |
Determination of fendiline and gallopamil by capillary isotachophoresis. | Journal of chromatography. B, Biomedical sciences and applications 20010615 |
Dual effect of the antianginal drug fendiline on bladder female transitional carcinoma cells: mobilization of intracellular CA2+ and induction of cell death. | Pharmacology 20010501 |
Fendiline-Induced Ca2+ movement in A10 smooth muscle cells. | The Chinese journal of physiology 20010331 |
The anti-anginal drug fendiline increases intracellular Ca(2+) levels in MG63 human osteosarcoma cells. | Toxicology letters 20010308 |
A new potent calmodulin antagonist with arylalkylamine structure: crystallographic, spectroscopic and functional studies. | Journal of molecular biology 20000331 |
Crystallization and preliminary diffraction analysis of Ca(2+)-calmodulin-drug and apocalmodulin-drug complexes. | Proteins 19970501 |
[The relationship between anticonvulsant and anti-anxiety effects of calcium channel blockers]. | Eksperimental'naia i klinicheskaia farmakologiia 19970101 |
Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta. | The Journal of pharmacology and experimental therapeutics 19920501 |
Effects of the calmodulin antagonists fendiline and calmidazolium on aggregation, secretion of ATP, and internal calcium in washed human platelets. | Naunyn-Schmiedeberg's archives of pharmacology 19910101 |
© 2019 Angene International Limited. All rights Reserved.